-
-
Editor's Choice -
Finance -
Pharma & Human Health -
Editor's Choice
Editor’s Choice
Editor's Choice
A microbiome therapeutic is closer than ever to market authorization in the US. What does it mean for the industry?
Ferring Pharmaceuticals, Inc. has edged ahead in the race to bring the first microbiome-based drug to market in the United States, with its product REBYOTA receiving the thumbs up from the FDA’s Vaccines and Related […]
Editor's Choice
Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660
Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) issued a positive vote for RBX2660, an investigational microbiota-based live biotherapeutic studied for its potential […]
Editor's Choice
Stanford researchers construct most complex, complete synthetic microbiome
Key studies in the last decade have shown that the gut microbiome, the collection of hundreds of bacterial species that live in the human digestive system, influences neural development, response to cancer immunotherapies, and other […]
In Case you Missed it:
Finance
Gensaic enters into collaboration to develop phage-derived gene therapies for CNS
Gensaic, a company that seeks to reimagine gene therapy, announced today that it has entered into a strategic collaboration agreement with Ovid Therapeutics. Under the terms of the collaboration, Gensaic will exclusively develop phage-derived gene […]
Pharma & Human Health
Phage resistant Escherichia coli strains developed to reduce fermentation failure
A genome engineering-based systematic strategy for developing phage resistant Escherichia coli strains has been successfully developed through the collaborative efforts of a team led by Professor Sang Yup Lee, Professor Shi Chen, and Professor Lianrong […]
Pharma & Human Health
Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes
For the first time, scientists have designed a phage combination therapy that can precisely target and suppress gut bacteria associated with inflammatory bowel diseases (IBD). Presented on August 4 in the journal Cell, the work […]
Pharma & Human Health
A focus on two critical needs for developing new products in the biotics industry
Consumers are increasingly focused on health and nutrition in their decision-making. Alongside this, interest and understanding of the importance of the gut microbiota in health and disease continues to grow. The global market for functional […]
Pharma & Human Health
New needle-free nasal vaccine shows promise for COVID-19
New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mBio, an open access journal of the American Society for Microbiology. In recent […]
Pharma & Human Health
Expanding the range of foods that can improve health via the gut microbiome
Consuming high amounts of dietary fiber is beneficial for health, and recent nutrition research has shown that the benefits of some dietary fibers are attributable to the gut microbiota. When these fibers are consumed by […]
Pharma & Human Health
The retron switch
Since first discovered in the 1980s, retrons have puzzled researchers who simply wanted to know what these bacterial DNA sequences actually did. Now, EMBL scientists have identified that some retrons encode toxin proteins, which they […]
Pharma & Human Health
Machine learning begins to understand the human gut
The communities formed by human gut microbes can now be predicted more accurately with a new computer model developed in a collaboration between biologists and engineers, led by the University of Michigan and the University […]
